Get a preview of Chile Connected's anticipated HealthTech panel

Q&A

Get ready for a fascinating panel. Photo by WebPhotographeer/Getty

The technology and innovation portion of Chile Connected begins next week, and if you haven't already reserved your free spot for the virtual event, you'd be wise to go do it now.

From October 27-29, you can hear from high-level experts and keynote speakers from both Chile and the U.S, as well as network and make new connections that will hopefully lead to a successful partnership.

Josh Sol, the administrative director of Houston Methodist Innovation and Ambulatory Clinical Systems, will be moderating the panel on October 29. The topic is "The Present Future of HealthTech," and will address what COVID-19 means for the future of healthcare technology.

Panelists include Daniela Mendoza, commercial manager for GenoSUR; Alberto Rodríguez-Navarro, founder of Levita Magnetics; and John Dvor, managing director of Miraki Innovation.

InnovationMap recently spoke with Sol about the upcoming event.

InnovationMap: What can U.S. companies gain from participating in this session?

Josh Sol: U.S. companies have the opportunity to gain additional perspectives from other like-minded individuals who are passionate about technology. I've been impressed from the groups and ProChile representatives I have spoken with to date, and I look forward to hearing more about innovation efforts coming from a leading Latin American technology epicenter.

IM: How important are international partnerships in the health tech sector?

JS: Innovation in healthcare technology is coming from all over the globe. Cultural experiences tend to drive creation and innovation. When we collaborate with partners outside of the U.S., we have the opportunity to broaden opportunities and learn from other cultures, and, in turn, we have the potential to apply those insights to what our standard processes are within the U.S. healthcare system.

IM: Personally, why did you feel it important to be involved with Chile Connected?

JS: I have been so impressed by the passion coming from Chile Connected. Discovering new companies doing amazing things in the healthcare technology space continues to fuel my passion for what I do on a day-to-day basis.

IM: What are the key ways businesses can adapt in the pandemic environment?

JS: Businesses should be as nimble as they can — that's a pretty universal lesson most have experienced and we've certainly had first-hand experience in this area as well. At Houston Methodist, our focus is always keeping the patient at the center of everything we do, and we appreciate the collaborative business partners who help us maintain our commitment to our patients, the community, and our clinicians during the pandemic.

Some partners have even pivoted their technology offerings to align with the challenges spurred by COVID. Some areas where we have had to adapt during COVID include ramping up our telemedicine efforts, quickly turning on our virtual ICU, and diversifying the way we communicate with our patients through digital technology.

IM: What do you think is important for start-ups to focus on when trying to grow in this field?

JS: Healthcare technology organizations have many opportunities available to them and must be open to change and the innovations coming from younger start-up companies. As a start-up, it's important to know the problem you are attempting to solve, and to also understand the bigger picture of either the process, patient experience, or clinician experience you are impacting.

Too often, a company will say, "What do you want it to do? It can do anything…" Always come with a solution mindset. Drill down into your offering and what value you have to the organization you're pitching to.

Reserve your free spot for Chile Connected now.

Form international partnerships without ever leaving home. Photo by Luis Alvarez/Getty

5 reasons to get connected with Chile via this virtual event

Listen to the List

It's almost time for the tech and innovation portion of Chile Connected, a nearly month-long virtual event designed to serve as a "matchmaker" for technology firms as well as creative industries, healthy food providers, and women-led businesses.

Sponsored by ProChile, the online convention is an easy — and free — way to meet your next possible collaborator, all from the comfort of home.

To make sure you don't miss your shot at building the next big partnership, here's everything you need to know.

1. The when and where
Chile Connected runs online October 19-November 20, with the tech and innovation panels taking place October 27-29. It's free to attend and you can register here.

2. What to expect
In addition to B2B matchmaking sessions, you can hear Chilean entrepreneurs about about their global innovations in the areas of HealthTech, FinTech, EdTech, and RetailTech. Experts will explore the future of e-commerce, how to empower women in tech, and how healthcare technology is changing in the face of COVID-19.

3. Who'll be there

  • HealthTech: Alberto Rodriguez, president of Levita Magnetic, a company that develops technology through magnets to reduce the need for incisions, invasive surgeries, and scars.
  • RetailTech: Ariel Schilkrut, cofounder of Zippedi Inc. Zippedi is a robot that uses AI to provide services to the retail industry. It includes image recognition and deep learning to create inventories, which improves the efficiency of replenishment processes and the level of service that these companies provide to their customers.
  • EdTech: Komal Dadlani, CEO and cofounder of Lab4U, a company that transforms mobile devices into scientific instruments to democratize access to science, giving the possibility of having a laboratory in your pockets.
  • EdTech: Marisol Alarcón from social de Laboratoria, a company that trains women without higher education as web developers. This undertaking was highlighted by Mark Zuckerberg and Barack Obama for its contribution to gender equality.
  • Fintech: Cristóbal Forno, founding partner of Global 66, a platform for international money transfers.

But that's just the start — besides the big names from even bigger companies, there will be dozens of people from all over the world looking to network and form partnerships.

4. Why you should consider Chile
Chile is recognized as the most advanced IT market in Latin America, with the IT sector there representing 3.4 percent of its national GDP. Chile is also the 29th largest trading partner of the United States, while America is the No. 1 destination for non-copper goods and service exports from Chile.

5. How Chile benefits you
Most Chilean companies — 53 percent, in fact — are looking for a joint venture or capital to grow into other markets. Chile has been regularly investing not only money but also resources and programs to support new startups and companies. Start-up Chile is one such accelerator; it has vowed to invest $80,000 in an American start-up that will create and develop its idea in Chile.

Reserve your free spot for Chile Connected now.

Your next game-changing parter might be in Chile. Photo by Klaus Vedfelt/Getty

Why your tech company should partner with forward-thinking Chile

Find Your Match

What's one of the most important ways a tech company can ensure success? Collaboration. Finding that perfect fit with a like-minded partner just might change the world — but first you have to find each other.

For many U.S.-based companies, their next great collab could be Chile. The South American country has recently been attracting the attention of big-name players such as Jeff Bezos, all based off its growing IT presence and expansion in the HealthTech, FinTech, EdTech, and RetailTech sectors.

But you don't have to actually travel to Chile to meet possible partners.

Chile Connected, sponsored by ProChile, is a nearly month-long virtual event designed to serve as a "matchmaker" for technology firms as well as creative industries, healthy food providers, and women-led businesses. And it's completely free to attend.

On October 27-29, the tech and innovation panel will welcome high-level experts and keynote speakers from both Chile and the U.S.

You'll hear from top-level execs at rapidly growing companies like biotech start-up GenoSUR and magnetics surgery pioneer Levita, both Chilean-based with American partnerships. Levita founder Alberto Rodriguez-Navarro will share the stage with GenoSUR's commercial manager Daniela Mendoza, along with a representative from CIC Health, which is innovating in COVID-19 rapid testing.

You also get to network and make new connections, hopefully leading to a successful partnership.

Most Chilean companies — 53 percent, in fact — are looking for a joint venture or capital to grow into other markets. U.S. companies then get the opportunity to select those which best suit their needs or have the most potential, as well as purchase up-and-coming software and other tech products at a very competitive price.

Chile has been regularly investing not only money but also resources and programs to support new startups and companies. Start-up Chile is one such accelerator that has vowed to invest $80,000 in an American start-up that will create and develop its idea in Chile.

So the money, know-how, and support are just waiting in Chile for the American businesses to come find it, and Chile Connected is where you can get started. Reserve your free spot for the event here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”

View All Listings